SciELO - Scientific Electronic Library Online

 
vol.63 número2Uso de tocilizumab en pacientes hospitalizados durante la primera ola de la pandemia COVID-19Cimicifuga racemosa (L.) Nutt. en el tratamiento de los síntomas vasomotores de la menopausia: revisión índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Ars Pharmaceutica (Internet)

versão On-line ISSN 2340-9894

Resumo

BONILLA-PLAZA, Jaime Andrés et al. Lower back pain after iodine-131-6-β-iodomethyl-19-norcholesterol injection: a case report. Ars Pharm [online]. 2022, vol.63, n.2, pp.173-177.  Epub 25-Abr-2022. ISSN 2340-9894.  https://dx.doi.org/10.30827/ars.v63i2.23505.

The [131I]Iodine-6-β-iodomethyl-19-norcholesterol ([131I]Norcholesterol; NP-59), is indicated in the diagnosis of the functional state of adrenal cortical tissue, in the detection of functional tissue in hyperadrenocorticalism as well as in primary aldosteronism. We present the case of a 54-year-old woman, referred for evaluation of suspected aldosteronism, and who immediately after intravenous administration of [131I]Norcholesterol suffered a strong adverse drug reaction, with dizziness, flushing, increased blood pressure, chest tightness, low back pain and erythematous rash up to 9 days after injection. Symptoms resolved satisfactorily after administration of antihistamines and corticosteroids. This reaction was suspected to be related to the administration of [131I]Norcholesterol caused by a type I allergic reaction.

Palavras-chave : NP-59; adverse drug reaction; pharmacovigilance.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )